Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/medtech/roche-inks-200m-licensing-pact-freenomes-cancer-screening-blood-tests" hreflang="en">Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests</a>
Roche will make a new $75 million equity investment in Freenome, toward the goal of developing blood testing kits for markets outside the U.S.
David Roche expects controlled market correction in next six months - The Economic Times
David Roche expects controlled market correction in next six months The Economic Times
Top Stock Reports for Alphabet, Roche & RTX - Nasdaq
Top Stock Reports for Alphabet, Roche & RTX Nasdaq
Lineage Cell says first OpRegen development milestone under Roche pact achieved - TipRanks
Lineage Cell says first OpRegen development milestone under Roche pact achieved TipRanks
Veeva Announces Expanded Partnership with Roche - MarketScreener
Veeva Announces Expanded Partnership with Roche MarketScreener
Roche Adopts Veeva Vault CRM - Contract Pharma
Roche Adopts Veeva Vault CRM Contract Pharma
Lakers jersey history No. 15 — John Roche - LeBron Wire
Lakers jersey history No. 15 — John Roche LeBron Wire
Stephen M. Roche Obituary November 22, 2025 - Bond Funeral Home
Stephen M. Roche Obituary November 22, 2025 Bond Funeral Home
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Roche inks $200M pact for Freenome's cancer screening blood test Fierce Biotech
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
Roche inks deal for rights to Freenome cancer tests outside US MedTech Dive
Regeneron wins 2 Eylea nods, ramping up competition with Roche - Fierce Pharma
Regeneron wins 2 Eylea nods, ramping up competition with Roche Fierce Pharma
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) - The Globe and Mail
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) The Globe and Mail
Freenome teams up with Roche for cancer screening tests - MobiHealthNews
Freenome teams up with Roche for cancer screening tests MobiHealthNews
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) - Seeking Alpha
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) Seeking Alpha
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests Yahoo Fi...
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
Freenome and Roche partner on cancer screening technology for ex-US markets Medical Device Network
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma Yahoo Finance
Roche pill notches win in early breast cancer - BioPharma Dive
Roche pill notches win in early breast cancer BioPharma Dive